Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$21.71 n/a | n/a%
06/23/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 570.45M 402.36M 276.57M 246.57M
Cost of Sales 371.23M 259.44M 183.54M 155.52M
Gross Operating Profit 199.22M 142.91M 93.03M 91.05M
Selling, General, and Administrative Expenses 122.14M 77.95M 50.52M 45.02M
Research & Development 16.05M 5.47M 1.00M 414.00K
Operating Income before D & A (EBITDA) 61.04M 59.49M 41.51M 45.62M
Depreciation & Amortization 66.42M 36.08M 25.66M 16.40M
Interest Income 0.00 0.00 0.00 11.00K
Other Income - Net -1.28M 2.22M 1.05M 1.08M
Special Income / Charges -3.13M -3.77M -7.83M -1.86M
Total Income Before Interest Expenses (EBIT) -20.04M 15.87M 5.49M 21.26M
Interest Expense 39.92M 19.34M 10.96M 1.56M
Pre-Tax Income -59.96M -3.47M -5.47M 19.70M
Income Taxes 10.21M -1.17M -2.19M 7.93M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -70.17M -2.30M -3.28M 11.77M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -70.17M -2.30M -3.28M 11.77M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -70.17M -2.30M -3.28M 11.77M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-56.79M 7.46M 8.14M 20.81M
Preferred Dividends
Net Income Available To Common -70.17M -2.30M -3.28M 11.77M
Basic EPS from Continuing Ops. -1.83 -0.07 -0.10 0.38
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.83 -0.07 -0.10 0.38
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.83 -0.07 -0.10 0.38
Basic Normalized Net Income/Share -1.48 0.23 0.25 0.67
EPS fr Continuing Ops. -1.83 -0.07 -0.10 0.37
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.83 -0.07 -0.10 0.37
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.83 -0.07 -0.10 0.37
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.48 0.23 0.25 0.65
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter